Roberto Herrera

ORCID: 0000-0003-1027-8981
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Glioma Diagnosis and Treatment
  • Adrenal and Paraganglionic Tumors
  • Lung Cancer Diagnosis and Treatment
  • Inflammatory Biomarkers in Disease Prognosis
  • MRI in cancer diagnosis
  • Pancreatic and Hepatic Oncology Research
  • Brain Metastases and Treatment
  • Radiation Therapy and Dosimetry
  • Psidium guajava Extracts and Applications
  • Viral Infections and Immunology Research
  • Allelopathy and phytotoxic interactions
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cardiomyopathy and Myosin Studies
  • Aortic aneurysm repair treatments
  • Aortic Disease and Treatment Approaches
  • Neuroblastoma Research and Treatments
  • Lung Cancer Research Studies
  • Testicular diseases and treatments
  • Hematological disorders and diagnostics
  • Pericarditis and Cardiac Tamponade
  • Pregnancy and preeclampsia studies
  • Meningioma and schwannoma management

Miami Heart Research Institute
2025

Baptist Hospital of Miami
2021-2024

Baptist Health South Florida
2021-2024

Hospital Universitario Virgen de las Nieves
1998-1999

10.1016/s0735-1097(25)04280-9 article EN Journal of the American College of Cardiology 2025-03-30

Background/Objectives: Over the past decade, significant advances have been made in image-guided radiotherapy (RT) particularly with introduction of magnetic resonance (MR)-guided (MRgRT). However, optimal clinical applications MRgRT are still evolving. The intent this analysis was to describe our institutional utilization patterns and evolution therein, specifically as an early adopter within a center endowed multiple other technology platforms. Materials/Methods: We retrospectively...

10.3390/cancers17020208 article EN Cancers 2025-01-10

While dose escalation is associated with improved local control (LC) for adrenal gland metastases (AGMs), the proximity of gastrointestinal (GI) organs-at-risk (OARs) limits that can be safely prescribed via CT-based stereotactic body radiation therapy (SBRT). The advantages magnetic resonance-guided SBRT (MRgSBRT), including tumor tracking and online plan adaptation, facilitate safe escalation.

10.1016/j.ctro.2023.100719 article EN cc-by-nc-nd Clinical and Translational Radiation Oncology 2024-01-05

Compared with computed tomography, magnetic resonance (MR) image guidance offers significant advantages for radiation therapy (RT) that may be particularly beneficial reirradiation (reRT). However, clinical outcomes of MR-guided reRT are not well described in the published literature.We performed a single-institution retrospective safety and efficacy analysis patients treated on MRIdian Linac to targets within abdomen or pelvis using continuous intrafraction MR-based motion management...

10.1016/j.adro.2021.100840 article EN cc-by-nc-nd Advances in Radiation Oncology 2021-10-27

686 Background: Treatment-induced lymphopenia in pancreatic ductal adenocarcinoma (PDAC) patients after radiation therapy (RT) may negatively impact overall survival (OS). While non-ablative RT (NA-RT) is routine for borderline resectable (BRPC) and locally advanced (LAPC) PDAC, ablative (A-RT) has garnered increasing interest based on data suggesting improved clinical outcomes including OS. Absolute lymphocyte count (ALC) changes A-RT the potential association with spleen dose this setting...

10.1200/jco.2024.42.3_suppl.686 article EN Journal of Clinical Oncology 2024-01-20

Magnetic resonance-guided radiotherapy (MRgRT) is increasingly used in a variety of adult cancers. To date, published experience regarding the use MRgRT pediatric patients limited to two case reports. We report on for at our institution during four-year period and describe important considerations selection application this technology children.All treated with since inception between 4/2018 4/2022 were retrospectively reviewed. also evaluated all same who received either imaging or treatment...

10.3389/fonc.2022.1037674 article EN cc-by Frontiers in Oncology 2023-01-11

10.14410/2013.5.1.65.68 article EN Revista Médica del Hospital José Carrasco Arteaga 2013-03-30

569 Background: Dose escalated radiation therapy (RT) may improve long-term clinical outcomes compared to standard dose for patients with initially inoperable pancreatic ductal adenocarcinoma (PDAC). Favorable have recently been reported of ablative stereotactic magnetic resonance image-guided adaptive (SMART) delivered in 5 fractions. The appropriateness SMART PDAC advanced age (>75 years) is not well understood. Methods: A retrospective analysis was performed non-metastatic aged 75 year...

10.1200/jco.2022.40.4_suppl.569 article EN Journal of Clinical Oncology 2022-01-19
Coming Soon ...